Identity
- Security key
- 12452
- Ticker
- BFRI
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2021-10-29
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- BFRI
Detail
Enriched 2026-08-14 20:47
- Market cap
- $16,004,180
- Shares outstanding (class)
- 12,803,344
- Shares outstanding (weighted)
- 12,803,344
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 94
- Location
- WOBURN, MA
- Homepage
- https://www.biofrontera-us.com
- Description
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.